Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study.

MLA

Salati, Massimiliano, et al. “Third-Line Chemotherapy in Advanced Biliary Cancers (ABC): Pattern of Care, Treatment Outcome and Prognostic Factors from a Multicenter Study.” Expert Review of Gastroenterology & Hepatology, vol. 16, no. 1, Jan. 2022, pp. 73–79. EBSCOhost, https://doi.org/10.1080/17474124.2022.2017772.

APA

Salati, M., Rizzo, A., Merz, V., Messina, C., Francesco, C., Gelsomino, F., Spallanzani, A., Ricci, A. D., Palloni, A., Frega, G., De Lorenzo, S., Carotenuto, P., Pettorelli, E., Benatti, S., Luppi, G., Melisi, D., Brandi, G., & Dominici, M. (2022). Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study. Expert Review of Gastroenterology & Hepatology, 16(1), 73–79. https://doi.org/10.1080/17474124.2022.2017772

Chicago

Salati, Massimiliano, Alessandro Rizzo, Valeria Merz, Carlo Messina, Caputo Francesco, Fabio Gelsomino, Andrea Spallanzani, et al. 2022. “Third-Line Chemotherapy in Advanced Biliary Cancers (ABC): Pattern of Care, Treatment Outcome and Prognostic Factors from a Multicenter Study.” Expert Review of Gastroenterology & Hepatology 16 (1): 73–79. doi:10.1080/17474124.2022.2017772.